RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Zydus Erythromycin 500 mg Tablets Recall

Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed b

Updated April 29, 2026

Zydus Pharmaceuticals is recalling Erythromycin 500 mg tablets because they contain higher-than-safe levels of a potentially harmful chemical. If you take this antibiotic, do not use your current supply until you confirm with your pharmacy or doctor.

Is the Zydus Pharmaceuticals (USA) Inc recalled? Yes. This product was recalled by FDA on April 29, 2026. Details below.

What is recalled

Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle. Manufactured by Zydus Lifesciences Ltd. (Ahmedabad, India) and distributed by Zydus Pharmaceuticals (USA) Inc. (Pennington, NJ). NDC number: 70710-1048-3. Prescription-only medicine.

Am I affected

You are affected if you have a prescription bottle of Erythromycin 500 mg tablets with NDC number 70710-1048-3 from Zydus Pharmaceuticals.

What to do right now

Do not use this medication. Contact your pharmacy or prescribing doctor right away to report you have this recalled batch and ask about a safe replacement antibiotic. Do not throw away the tablets, your pharmacist may want to return them to the manufacturer.

The hazard

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Brands affected

Zydus Pharmaceuticals (USA) Inc
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0545-2026
Classification
Class II
Recalled
April 29, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls